VRXA · Forms 3, 4, 5
Insider trades at Veraxa Biotech AG - Post de-SPAC
2 insiders bought $83K of Veraxa Biotech AG - Post de-SPAC stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Veraxa Biotech AG - Post de-SPAC (VRXA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Raju Sudir Willener | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Oliver Rolf Baumann | Director | Buy | 50,000 | $1.50 | $75K | Form 4 | |
| Christoph Rudiger Antz | Chief Executive Officer | Buy | 5,000 | $1.53 | $8K | Form 4 | |
| Halem Carl von | Interim CFO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.